David Novak

Item: David Novak
Rating: 0.58
Author: StockAnalysis.com

Stock Analyst at Raymond James

(0.58)

# 4,121

Out of 5,165 analysts

Total ratings

42.86%

Success rate

-13.85%

Average return

Main Sectors:

Top Industries:

Stocks Rated by David Novak

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ZYME Zymeworks	Downgrades: Outperform	$74	$23.62	+213.29%	6	Dec 10, 2021
	CBIO Crescent Biopharma	Maintains: Outperform	$300 → $270	$11.70	+2,207.69%	1	Feb 4, 2021

Zymeworks

Dec 10, 2021

Downgrades: Outperform

Price Target: $74

Current: $23.62

Upside: +213.29%

Crescent Biopharma

Feb 4, 2021

Maintains: Outperform

Price Target: $300 → $270

Current: $11.70

Upside: +2,207.69%